American Journal of Obstetrics & Gynecology
Volume 188, Issue 6 , Pages 1556-1564, June 2003

Treatment of recurrent platinum resistant ovarian or peritoneal cancer with gemcitabine and doxorubicin: A phase I/II trial of the Puget Sound Oncology Consortium (PSOC 1602)☆☆☆

Presented at the Sixty-Ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, October 22-27, 2002, Rancho Mirage, Calif

Seattle, Wash

From the Department of Obstetrics and Gynecology,a University of Washington School of Medicine, Section of Hematology/Oncology, Virginia Mason Medical Center,b and Fred Hutchinson Cancer Research Center.c

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported in part by Lilly Oncology and the Fred Hutchinson Cancer Research Center.c

☆☆ Reprint requests: Barbara A. Goff, MD, Department of Obstetrics and Gynecology, Box 356460, University of Washington School of Medicine, Seattle, WA 98l95-6460.

PII: S0002-9378(03)00352-1

doi:10.1067/mob.2003.398

American Journal of Obstetrics & Gynecology
Volume 188, Issue 6 , Pages 1556-1564, June 2003

Article Tools

* Image Usage & Resolution